BioNTechPfizer

Pfizer and BioNTech’s Omicron-targeted Covid-19 vaccines elicit a strong immune response, significantly outperforming their previous vaccine at tackling the most prevalent variant,…

The US Food and Drug Administration has authorised the use of the BioNTech/Pfizer Covid-19 vaccine for children aged five to 11 years, paving the way for the US to become the first…

Newsletter: The Road to RecoveryExpert coverage of how business and the economy are recovering, post-pandemic. Delivered 3 times a week. The Biden administration’s plan for…

Covid-19 vaccines updatesSign up to myFT Daily Digest to be the first to know about Covid-19 vaccines news. The US Food and Drug Administration has granted full approval to…

Pfizer and BioNTech are preparing to start clinical trials of a version of their Covid-19 vaccine targeting the Delta variant next month, amid fears that existing jabs will…